NO923533L - Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika - Google Patents
Nye 5-amino-4-hydroksyheksansyrederivater som terapeutikaInfo
- Publication number
- NO923533L NO923533L NO92923533A NO923533A NO923533L NO 923533 L NO923533 L NO 923533L NO 92923533 A NO92923533 A NO 92923533A NO 923533 A NO923533 A NO 923533A NO 923533 L NO923533 L NO 923533L
- Authority
- NO
- Norway
- Prior art keywords
- terminally
- group
- bonded
- sulfo
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Forbindelser med formel: H OH (D, der Rj betyr hydrogen, laverealkoksykarbonyl, heterocyklylliarbonyl, benzylokeykarbonyl, som kan være ueubstltuert eller substituert ved inntil tre uavhengige av hverandre fluor, halogenlaverealkyl, laverealkanoyl, sulfo, laverealkylsulfonyl og cyano utvalgte rester, heterocyklyloksykarbonyl, der heterocyklyl kan vasre bundet over et karbonatom, en av de nevnte karbonylrestene der den bindende karbonylgruppen er erstattet med en tlokarbonyl- gruppe, heterocyklylBUlfonyl, laverealkylsulfonyl eller N-(heterocyklyllaverealkyl)-N-laverealkylaminokarbonyl, 3^ betyr en binding eller et toverdig radikal av en a-aminosyre som kan være N-terminalt bundet med R! og C-termlnalt bundet med atninogruppen til R2-CH2-bærende karbonatom, R2 og R3 betyr uavhengig av hverandre fenyl eller cytlohek- syl, der restene kan være usubstituert eller substituert med en til tre uavhengig av hverandre hydroksy, lavere- alkoksy, halogen, halogenlaverealkyl, sulfo, laverealkylsulfonyl. cyano og nitro utvalgte rester, J^ betyr en binding mellom -C-0 og A2 eller et toverdig radikal av en a-amlnosyre, som kan vare N-terminalt bundet med gruppen -C-0 og C-termlnalt bundet med A2, A2 betyr en toverdig radikal av en a-aminosyre. som kan vare bundet N-terminalt med Aj og C-termlnalt med gruppen NR4RB, eller Aj og A2 sammen danner et toverdig radikal av et dlpeptld, hvis sentrale amidblndlng er redusert og forbundet N-termlnalt med gruppen -C-0 og C-termlnalt med gruppen NR4RB, og R4 og RB betyr sammen med det bindende nltrogenatomet usubstituert eller substituert tlomorfolino eller morfollno, og salter av disse forbindelsene så fremt saltdannende grupper foreligger, eller hydroksybeskyttende derivater av disse. Disse HIV-proteasehemmerne kan anvendes til behandling av AIDS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH268991 | 1991-09-12 | ||
CH98092 | 1992-03-27 | ||
CH200792 | 1992-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO923533D0 NO923533D0 (no) | 1992-09-11 |
NO923533L true NO923533L (no) | 1993-03-15 |
Family
ID=27172572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92923533A NO923533L (no) | 1991-09-12 | 1992-09-11 | Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0532466A3 (no) |
JP (1) | JPH05230095A (no) |
KR (1) | KR930006050A (no) |
AU (1) | AU661018B2 (no) |
CA (1) | CA2077948A1 (no) |
CZ (1) | CZ280292A3 (no) |
FI (1) | FI924035A (no) |
HU (1) | HUT63632A (no) |
IL (1) | IL103126A (no) |
MX (1) | MX9205208A (no) |
NO (1) | NO923533L (no) |
NZ (1) | NZ244288A (no) |
PL (1) | PL169969B1 (no) |
RU (1) | RU2067585C1 (no) |
SK (1) | SK280292A3 (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643878A (en) * | 1991-09-12 | 1997-07-01 | Ciba-Geigy Corporation | 5-amino-4-hydroxyhexanoic acid derivatives |
ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
CA2130754C (en) * | 1992-03-11 | 2005-02-08 | Damian W. Grobelny | Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
TW217410B (no) * | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
ES2093394T3 (es) | 1992-12-23 | 1996-12-16 | Ciba Geigy Ag | Derivados de hidrazina antiretrovirales. |
EP0618222A3 (en) * | 1993-03-11 | 1997-01-02 | Ciba Geigy Ag | Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid. |
EP0626178A1 (de) * | 1993-05-17 | 1994-11-30 | Ciba-Geigy Ag | Verwendung von Hemmstoffen von HIV-Aspartatproteasen zur Bekämpfung von Tumorerkrankungen |
IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) * | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) * | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
WO1996016980A1 (en) * | 1994-11-29 | 1996-06-06 | Novartis Ag | Morpholinoethylamide derivatives |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
US5840835A (en) * | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
WO1997016188A1 (en) * | 1995-10-30 | 1997-05-09 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
US7553969B1 (en) * | 1999-01-28 | 2009-06-30 | Chugai Seiyaku Kabushiki Kaisha | Substituted phenethylamine derivatives |
US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
KR100708221B1 (ko) | 1999-08-31 | 2007-04-17 | 아지노모토 가부시키가이샤 | 에폭사이드 결정의 제조방법 |
SI1248600T1 (sl) | 2000-01-19 | 2008-08-31 | Abbott Lab | Izboljšane farmacevtske formulacije inhibitorjev proteaze HIV |
US6506786B2 (en) | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
KR20050065661A (ko) * | 2002-11-01 | 2005-06-29 | 비로파마 인코포레이티드 | 벤조푸란 화합물, 조성물 및 c형 간염 바이러스 감염 및관련 질병의 치료 및 예방 방법 |
US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
US8227450B2 (en) | 2005-11-30 | 2012-07-24 | Ambrilia Biopharma Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
CN101374815B (zh) | 2006-01-27 | 2013-07-17 | 菲布罗根有限公司 | 使低氧诱导因子(hif)稳定的氰基异喹啉化合物 |
BRPI0710527B8 (pt) | 2006-04-04 | 2021-05-25 | Fibrogen Inc | compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende |
US8410300B2 (en) | 2006-09-21 | 2013-04-02 | Taimed Biologics, Inc. | Protease inhibitors |
JP5649584B2 (ja) | 2008-11-14 | 2015-01-07 | フィブロジェン インコーポレイテッド | Hifヒドロキシラーゼ阻害剤としてのチオクロメン誘導体 |
RU2666144C2 (ru) | 2013-01-24 | 2018-09-06 | Фиброген, Инк. | Кристаллические формы { [1-циано-5-(4-хлорофенокси)-4-гидроксиизохинолин-3-карбонил]-амино} -уксусной кислоты |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126326A (en) * | 1989-06-06 | 1992-06-30 | Bio-Mega, Inc. | Enzyme inhibiting peptide derivatives |
-
1992
- 1992-09-03 EP EP19920810678 patent/EP0532466A3/de not_active Ceased
- 1992-09-07 JP JP4238424A patent/JPH05230095A/ja active Pending
- 1992-09-09 KR KR1019920016530A patent/KR930006050A/ko not_active Application Discontinuation
- 1992-09-09 FI FI924035A patent/FI924035A/fi not_active Application Discontinuation
- 1992-09-10 AU AU22889/92A patent/AU661018B2/en not_active Ceased
- 1992-09-10 NZ NZ244288A patent/NZ244288A/en unknown
- 1992-09-10 CA CA002077948A patent/CA2077948A1/en not_active Abandoned
- 1992-09-10 IL IL103126A patent/IL103126A/xx not_active IP Right Cessation
- 1992-09-11 PL PL92295905A patent/PL169969B1/pl unknown
- 1992-09-11 HU HU9202925A patent/HUT63632A/hu unknown
- 1992-09-11 SK SK2802-92A patent/SK280292A3/sk unknown
- 1992-09-11 MX MX9205208A patent/MX9205208A/es not_active IP Right Cessation
- 1992-09-11 NO NO92923533A patent/NO923533L/no unknown
- 1992-09-11 CZ CS922802A patent/CZ280292A3/cs unknown
- 1992-09-11 RU SU925052915A patent/RU2067585C1/ru active
Also Published As
Publication number | Publication date |
---|---|
PL169969B1 (pl) | 1996-09-30 |
MX9205208A (es) | 1993-03-01 |
FI924035A0 (fi) | 1992-09-09 |
NZ244288A (en) | 1995-03-28 |
AU2288992A (en) | 1993-03-18 |
PL295905A1 (en) | 1993-05-17 |
CZ280292A3 (en) | 1994-01-19 |
KR930006050A (ko) | 1993-04-20 |
HU9202925D0 (en) | 1992-11-30 |
IL103126A (en) | 1997-09-30 |
RU2067585C1 (ru) | 1996-10-10 |
JPH05230095A (ja) | 1993-09-07 |
HUT63632A (en) | 1993-09-28 |
EP0532466A2 (de) | 1993-03-17 |
FI924035A (fi) | 1993-03-13 |
AU661018B2 (en) | 1995-07-13 |
NO923533D0 (no) | 1992-09-11 |
SK280292A3 (en) | 1995-02-08 |
IL103126A0 (en) | 1993-02-21 |
CA2077948A1 (en) | 1993-03-13 |
EP0532466A3 (en) | 1993-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO923533L (no) | Nye 5-amino-4-hydroksyheksansyrederivater som terapeutika | |
YU66201A (sh) | Derivati amina kao inhibitori proteaze | |
ATE326454T1 (de) | Neue bernsteinsäure derivative als cysteine- protease-inhibitoren | |
TW370529B (en) | Pyrazolopyrimidines | |
DK0944617T3 (da) | Krystaller af benzimidazolderivater og deres fremstilling | |
DK436081A (da) | Substituerede acyl-derivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyrer og farmaceutisk acceptable salte deraf fremgangsmaade til deres fremstilling og deres anvendelse | |
NO20060703L (no) | Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater | |
NO954975L (no) | Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider | |
ATE90107T1 (de) | Peptide mit collagenase hemmender wirkung. | |
DK142084A (da) | N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf | |
RS20050182A (en) | Derivatives of dioxane-2-alkyl carbamates,preparation method thereof and application of same in therapeutics | |
EP0353955A3 (en) | Novel compounds | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
WO2003008379A1 (fr) | Composes azasucre | |
MY103348A (en) | Heteroaryl 3-0x0-propanenitrile derivatives and process for their preparation | |
CO4950567A1 (es) | Inhibidores de proteasas dores de proteasas. | |
AU2003207432A1 (en) | Urea linker derivatives for use as ppar modulators | |
NO964698L (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
EP0202062A3 (en) | Quinuclidine derivatives | |
MX2007004482A (es) | Derivados de piridina y la preparacion y el uso terapeutico de los mismos. | |
YU46937B (sh) | Derivati kondenzovanog pirazol-3-okso-propannitrila i postupak za njihovo dobijanje | |
DK0526313T3 (da) | Nye ureaderivater, deres fremstilling og terapeutiske anvendelse | |
YU46706B (sh) | Postupak za dobijanje amidnih jedinjenja | |
TW333532B (en) | Benzopyrans | |
DE69910083D1 (de) | Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten |